|
L
1.
|
Estimating the national wage loss from cancer in Canada Hopkins, R. B.; PATH Research Institute - Goeree, R.; PATH Research Institute - Longo, C. J.; McMaster University
|
|
L
2.
|
A pan-Canadian practice guideline and algorithm: screening, assessment, and supportive care of adults with cancer-related fatigue Howell, D.; University of Toronto, Princess Margaret Hospital - Keller-Olaman, S.; University of Toronto - Oliver, T.K.; Canadian Partnership Against Cancer - Hack, T.F.; University of Manitoba, Cancer Care Manitoba - Broadfield, L.; Cancer Care Nova Scotia - Biggs, K.; Juravinski Cancer Centre - Chung, J.; British Columbia Children’s Hospital - Gravelle, D.; Élisabeth Bruyère Hospital - Green, E.; Montreal General Hospital - Hamel, M.; Montreal General Hospital - Harth, T.; Odette Cancer Centre - Johnston, P.; Cancer Care Manitoba - McLeod, D.; Cancer Care Nova Scotia - Swinton, N.; Jewish General Hospital - Syme, A.; Covenant Health - Olson, K.; University of Alberta
|
|
L
3.
|
Oxaliplatin: a review in the era of molecularly targeted therapy Alcindor, T.; McGill University Health Centre - Beauger, N.
|
|
L
4.
|
Occult cause of paraneoplastic acanthosis nigricans in a patient with known breast dcis: case and review Jakubovic, B. D.; Faculty of Medicine, University of Toronto, Toronto, ON. - Sawires, H. F.; Division of General Surgery & Surgical Oncology, Toronto East General Hospital, University of Toronto, Toronto, ON. - Adam, D. N.; Department of Medicine, Division of Dermatology, St. Michael’s Hospital, University of Toronto, Toronto, ON.
|
|
L
5.
|
Primary central nervous system T-cell lymphoma in AIDS patients: case report and literature review Latta, S.; Saint Joseph Hospital/University of Illinois - Myint, Z.W. - Jallad, B. - Hamdi, T. - Alhosaini, M.N. - Kumar, D.V. - Kheir, F.
|
|
L
6.
|
Optimal prophylactic and definitive therapy for bicalutamide-induced gynecomastia: results of a meta-analysis Tunio, M. A.; Department of Radiation oncology, King Fahad Medical City (KFMC) Riyadh, Saudi Arabia - Al-Asiri, M.; Consultant Radiation Oncology Prince Suleman Hematology and Oncology Center King Fahad Medical City (KFMC) Riyadh - Al-Amro, A.; Consultant Radiation Oncology Prince Suleman Hematology and Oncology Center King Fahad Medical City (KFMC) Riyadh - Bayoumi, Y.; Consultant Radiation Oncology Prince Suleman Hematology and Oncology Center King Fahad Medical City (KFMC) Riyadh - Fareed, M.; Assistant Consultant Radiation Oncology Prince Suleman Hematology and Oncology Center King Fahad Medical City (KFMC) Riyadh
|
|
L
7.
|
Overall survival should be the primary endpoint in clinical trials for advanced non-small cell lung cancer Cheema, P.K.; Sunnybrook Health Sciences Centre/Odette Cancer Centre - Burkes, R.L.; Mount Sinai Hospital, and University of Toronto
|
|
L
8.
|
Exercise and nutrition interventions in advanced lung cancer: a systematic review Payne, C.; University of Ulster - Larkin, P.J.; University College Dublin, Our Lady’s Hospice and Care Services - McIlfatrick, S.; University of Ulster - Dunwoody, L.; University of Ulster - Gracey, J.H.; University of Ulster
|
|
L
9.
|
Rash rates with EGFR inhibitors: meta-analysis Mittmann, N.; HOPE Research Centre, Sunnybrook Health Sciences Centre - Seung, S. J.; HOPE Research Centre, Sunnybrook Health Sciences Centre
|
|
L
10.
|
The role of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as Therapy for Advanced, Metastatic and Recurrent Non-Small Cell Lung Cancer: A Canadian National Consensus Statement Ellis, Peter - Morzycki, Wojciech - Melosky, Barbara - Butts, Charles - Hirsh, Vera - Krasnoshtein, Flora - Murray, Nevin - Shepherd, Frances A - Soulieres, Denis - Tsao, Ming-Sound - Goss, Glenwood
|
